Silverfox Digital Galvanic

The Silverfox Digital Galvanic is a professional facial treatment device designed to improve skin radiance and firmness, positioned as an advanced tool for spa-based facial services. It uses galvanic technology operated through a touch screen with a digital display, which the listing emphasises for precise, easy operation. It is aimed at professional spa and skincare practitioners, and at clinics and salons looking to expand their facial service menu. **Key points:** - Modality: galvanic current - a direct-current facial technique used in professional treatments for product infusion (iontophoresis) and deep-pore cleansing (desincrustation). Note that the listing itself states only 'galvanic technology' and does not itemise the modes. - Claimed benefits per the listing: improved skin radiance and firmness. - Controls: touch screen with digital display for precise, simple operation - a training-and-consistency advantage for multi-operator clinics. - Positioning: professional spa and clinic use, sold as a menu-expansion device rather than a capital-intensive platform. - Non-ablative and contact-based, so it pairs cleanly with exfoliation and infusion steps in an existing facial rather than requiring its own appointment type. **Business case:** Galvanic units are the classic low-cost menu expander: they add a chargeable 'active infusion' step to a facial at minimal capital outlay and no downtime, raising average revenue per appointment without extending room time or requiring a new client segment. **Confidence:** High for the device's positioning, galvanic modality, touch-screen controls and claimed radiance/firmness benefits - all stated in the product record; Medium for the iontophoresis/desincrustation detail, which is standard galvanic modality practice rather than a stated device mode in the listing. **Evidence source:** Product listing `silverfox-digital-galvanic` (id=1099), fields: lede, what_it_is, how_it_works, who_for.

The regulatory status of the Silverfox Digital Galvanic cannot be confirmed from the current product data. The structured fields `fda_key`, `fda_label` and `fda_tone` are empty on the product record, and the listing text contains no FDA clearance, CE marking or equivalent certification claim. No conclusion can be drawn about either clearance or non-clearance. **Key points:** - `fda_key`, `fda_label` and `fda_tone` are all empty. - No regulatory statement appears in the lede, what_it_is, how_it_works or who_for fields - the claims made ('improve skin radiance and firmness') are cosmetic benefit claims, not therapeutic or cleared indications. - Galvanic facial units are typically marketed as aesthetic/cosmetic equipment rather than as cleared medical devices, so there may be no FDA clearance to produce in this case; the absence must be confirmed in writing, not assumed. - If the supplier markets it for a therapeutic purpose, US Class II 510(k) requirements and 'cleared' terminology would apply. **⚠️ FLAG - procurement verification required.** Before purchase, obtain from the supplier: (1) written confirmation of whether any FDA 510(k) clearance exists and the indications it covers, or a statement that the device is marketed as cosmetic equipment only, (2) CE marking documentation to EU MDR 2017/745 or UKCA evidence for European deployment, (3) a signed regulatory status letter on company letterhead covering the exact model, (4) IEC 60601-1 electrical safety certification, and (5) the manufacturer's contraindication list for galvanic current (implanted electronic devices, pregnancy, metal implants, epilepsy). **Business case:** For low-cost galvanic units the compliance question is mostly about advertising: if you describe the device using therapeutic language in your marketing you move it into medical-device territory regardless of how the supplier positioned it. **Confidence:** Low - no FDA or equivalent regulatory information of any kind is present in the product data, so no status can be stated. **Evidence source:** Product listing `silverfox-digital-galvanic` (id=1099), fields: fda_key, fda_label, fda_tone, lede, what_it_is, how_it_works, who_for (all regulatory fields empty).

The listing describes the galvanic technology and the touch-screen control interface but publishes no session count or interval schedule, and it does not itemise treatment modes. Apply the standard galvanic facial protocol for this device class and confirm the exact schedule with the manufacturer: a course of 6-10 sessions spaced 1-2 weeks apart, then maintenance every 4-6 weeks, with each session typically run as two phases - a desincrustation (cleansing) phase followed by an iontophoresis (product-infusion) phase. **Key points:** - Course: 6-10 sessions at 1-2 week intervals is standard for galvanic facial programmes. - Session structure: galvanic treatments conventionally run a cleansing/desincrustation phase with one polarity, then an infusion phase with the reversed polarity - confirm the device's polarity and mode handling with the supplier, since the listing does not describe it. - The listing highlights a touch screen with digital display for precise, easy operation - which supports consistent, repeatable settings across operators and clients. - Downtime: none - galvanic is non-ablative and contact-based, so it fits into a standard facial appointment. - Maintenance: one session every 4-6 weeks sustains the radiance and firmness benefit and keeps the client on a monthly cycle. **Business case:** Because there is no downtime and no consumable beyond the treatment product itself, the galvanic step is best sold as a chargeable upgrade inside an existing facial - high margin, no extra room time, and it creates a natural monthly rebooking rhythm. **Confidence:** Medium - the modality, controls and claimed benefits are product-documented; the session counts, intervals and two-phase structure are standard clinical practice for galvanic facials rather than published device specifications. **Evidence source:** Product listing `silverfox-digital-galvanic` (id=1099), fields: lede, what_it_is, how_it_works, who_for.

The listing does not publish a Fitzpatrick skin-type restriction for the Silverfox Digital Galvanic, and it makes no skin-type claim at all. Galvanic current is non-ablative and contact-based, so skin-type pigmentation risk is low; the clinically significant safety questions are electrical (implanted devices) and product-related (the infused serum can irritate reactive skin). **Key points:** - No Fitzpatrick range, skin-type claim or contraindication list is present in the product record. - Absolute contraindications to screen for: implanted electronic devices (pacemakers, ICDs, neurostimulators), pregnancy, epilepsy, metal implants in the treatment path, and any broken or inflamed skin in the treatment area. - The infused product matters as much as the current: check the serum/conductor used for irritants, fragrance and photosensitisers, particularly for the iontophoresis (infusion) phase. - Galvanic current is polarity-dependent - the cleansing and infusion phases use opposite polarities, so ensure operators are trained on which product goes with which polarity to avoid driving irritants into the skin. - Skin types IV-VI are not specifically restricted; the device is a reasonable low-risk option where firming is wanted without a pigmentation risk. **Business case:** Galvanic treatments fail commercially when operators get polarity and product pairing wrong - the client reacts, and a cheap add-on service becomes a complaint. A written protocol sheet and one standardised conductor product remove most of that risk. **Confidence:** Low to Medium - the absence of any skin-type or contraindication information in the record is confirmed; the contraindication list and polarity guidance are standard clinical practice for galvanic current, not product-documented specifications. **Evidence source:** Product listing `silverfox-digital-galvanic` (id=1099), fields: lede, what_it_is, how_it_works, who_for.